IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.755
NA - Nord America 5.316
EU - Europa 2.091
SA - Sud America 639
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 76
OC - Oceania 29
Totale 23.007
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 11.038
US - Stati Uniti d'America 5.075
CN - Cina 1.620
IT - Italia 992
HK - Hong Kong 957
BR - Brasile 450
BD - Bangladesh 365
VN - Vietnam 310
GB - Regno Unito 283
FR - Francia 259
DE - Germania 169
IN - India 119
CA - Canada 115
MX - Messico 73
AR - Argentina 70
FI - Finlandia 60
NL - Olanda 58
ID - Indonesia 52
TR - Turchia 47
PL - Polonia 42
ES - Italia 37
ZA - Sudafrica 36
UA - Ucraina 35
EC - Ecuador 34
RU - Federazione Russa 34
AU - Australia 27
CZ - Repubblica Ceca 25
SA - Arabia Saudita 24
IQ - Iraq 22
JP - Giappone 22
PH - Filippine 22
PK - Pakistan 22
CO - Colombia 19
MY - Malesia 17
CL - Cile 16
VE - Venezuela 16
JM - Giamaica 14
CH - Svizzera 13
SE - Svezia 12
MA - Marocco 11
PY - Paraguay 11
PE - Perù 10
UZ - Uzbekistan 10
NP - Nepal 9
EG - Egitto 8
HN - Honduras 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
BH - Bahrain 7
JO - Giordania 7
OM - Oman 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
UY - Uruguay 7
AT - Austria 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
IE - Irlanda 6
LB - Libano 6
LT - Lituania 6
AL - Albania 5
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
DK - Danimarca 5
DZ - Algeria 5
KE - Kenya 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
KR - Corea 4
KZ - Kazakistan 4
MD - Moldavia 4
NI - Nicaragua 4
AM - Armenia 3
BG - Bulgaria 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
RS - Serbia 3
CM - Camerun 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
HT - Haiti 2
IS - Islanda 2
KW - Kuwait 2
LK - Sri Lanka 2
MN - Mongolia 2
MW - Malawi 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TL - Timor Orientale 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 22.894
Salva come PNG Salva come JPEG
Città #
San Jose 1.450
Singapore 1.046
Ashburn 967
Hong Kong 938
Rome 696
Hefei 495
Beijing 394
Council Bluffs 326
Boardman 265
Columbus 254
Dallas 239
Lauterbourg 221
London 207
Shanghai 195
Santa Clara 144
Ho Chi Minh City 118
Los Angeles 91
Munich 87
New York 81
San Francisco 62
Hanoi 55
Mexico City 52
São Paulo 52
Toronto 45
Seattle 43
West Jordan 41
Turku 38
Warsaw 37
Amsterdam 34
Washington 34
Pune 32
Buffalo 28
Montreal 24
Brno 22
Chennai 22
Helsinki 22
Orem 21
Rio de Janeiro 21
Brooklyn 20
Milan 20
Sona 20
Guangzhou 19
Manchester 19
Boston 17
Johannesburg 17
Tokyo 17
Chicago 16
Frankfurt am Main 16
Haiphong 16
Atlanta 15
Paris 14
Charlotte 13
Naples 13
Riyadh 13
Brasília 12
Da Nang 12
Guayaquil 12
Melbourne 12
Central 11
Lahore 11
Phoenix 11
Quito 11
Bologna 10
Kuala Lumpur 10
Las Vegas 10
Stockholm 10
Tashkent 10
Thái Bình 10
Canberra 9
Curitiba 8
Denver 8
Hangzhou 8
Istanbul 8
Moscow 8
Mumbai 8
New Delhi 8
Zhengzhou 8
Belo Horizonte 7
Brescia 7
Houston 7
Pasadena 7
Amman 6
Ankara 6
Bari 6
Bogotá 6
Campinas 6
Haikou 6
Jakarta 6
Jinan 6
Kingston 6
Kyiv 6
Medellín 6
Muscat 6
Ninh Bình 6
Poplar 6
Redmond 6
Secaucus 6
Baghdad 5
Baku 5
Bangkok 5
Totale 9.528
Salva come PNG Salva come JPEG
Nome #
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 253
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 253
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 249
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 243
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 235
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 234
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 234
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 233
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 232
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 231
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 231
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 231
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 228
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 228
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 227
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 227
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 224
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 220
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 218
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 218
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 217
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 217
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 215
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 214
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 214
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 211
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 210
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 209
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 205
Assessment of liver function by the exhaled breath-print during chronic liver disease 205
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 202
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 200
Blood glucose monitoring in the normal population: the PREDICA study 200
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 200
[Hepatocarcinoma: from epidemiology to gene therapy] 197
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 197
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 191
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 179
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 175
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 172
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 155
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 141
Anestesia e malattie non comuni 140
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 139
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 138
[A 73-year-old woman with vomiting and metabolic alkalosis] 137
Diabetes in chronic liver disease: from old concepts to new evidence 137
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 136
GH-resistance in different stages of chronic liver disease 135
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 135
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 133
A challenging alfa-fetoprotein in a cirrhotic patient 133
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 133
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 132
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 132
[A 74-year-old woman with macrocytic anemia] 129
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 128
Enhanced portal flow velocity and volume following Iloprost treatment 128
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 127
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 127
[A 61-year-old woman with abdominal pain and urination disorders] 127
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 124
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 123
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 122
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 121
Radiofrequency ablation of hepatic tissue: a new experimental animal model 119
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 118
Anesthesia & uncommon diseases 118
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 118
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 117
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 117
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 116
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 116
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 112
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 111
Breathprinting of liver diseases 111
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 110
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 110
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 109
Pain and Frailty in Hospitalized Older Adults 109
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 109
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 107
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 107
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 106
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 105
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 104
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 102
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 98
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 98
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 97
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 94
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 92
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 92
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 90
Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study 89
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 87
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 86
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 80
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 79
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 79
Totale 15.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20268.685 773 390 548 874 357 477 2.246 517 652 769 613 469
2026/2027753 150 603 0 0 0 0 0 0 0 0 0 0
Totale 23.007